Latest News

A study finds postmenopausal women have higher rates of dry eye disease, emphasizing the need for routine screening in clinical practice.

Levonorgestrel IUD offers localized progesterone delivery for endometrial protection during hormone therapy, with minimal systemic effects.

Melissa Mauskar, MD, discusses overlapping vulvar conditions, patient counseling, and the importance of multidisciplinary care

Real-world data show fezolinetant improves vasomotor symptoms, sleep, and work productivity in postmenopausal women.

At The Menopause Society Annual Meeting, Caroline Mitchell, MD, MPH, emphasized individualized, evidence-based care and the safety of topical hormones for GSM.

Starting estrogen therapy in perimenopause was associated with reduced risks of breast cancer, heart attack, and stroke, study shows.

A new study found that transdermal hormone therapy may lower anxiety and depression risk compared with oral therapy in postmenopausal women.

Menopause remains a taboo topic in many cultures, yet women seek to educate themselves and support each other through shared experiences.

A Wake Forest study finds that provider specialty and training shape how women receive medication treatment for menopause symptoms.

Most perimenopausal and menopausal women report digestive symptoms, but few receive diagnosis or adequate care, new UK study finds.

Researchers highlight overlap between menopause and TBI symptoms, calling for hormone-informed tools in brain injury assessment.

Tebipenem HBr met primary endpoints in a phase 3 trial, showing oral efficacy comparable to IV carbapenem for complicated urinary tract infections.

A study reveals a sharp rise in telehealth medication abortion use following the Dobbs v Jackson Women’s Health Organization ruling.

A review presented at The Menopause Society 2025 highlights the links between menopause-related brain changes and cognitive function.

A large TriNetX analysis found hormone therapy use in postmenopausal women was linked to a higher incidence of autoimmune diseases.

In a study led by Eugene Declercq, PhD, MBA, infants born to mothers who died during or after pregnancy faced higher mortality rates.

A study found that prenatal exposure to antenatal corticosteroids increases the long-term risk of respiratory and nonrespiratory infections.

Moe Takenoshita, MBBCh, found that cesarean delivery was linked to a 16% higher risk of developing sleep disorders within a year after childbirth.

Complications from pelvic floor polypropylene mesh appear linked to host immune response rather than oxidative material degradation.

A study found no link between first-trimester mRNA COVID-19 vaccine exposure and major congenital malformations.

Eve Zaritsky, MD, reports that e-visits are a safe, effective, and accessible option for patients seeking oral contraceptives.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A new study found that the severity of pelvic pain in patients with endometriosis affects health-related quality of life through the influence of coping mechanisms.

A new device identifies HMGB1 in period blood with 500% greater sensitivity, offering a faster alternative for diagnosing endometriosis.

New research from Penn State reveals that endometriosis disrupts the autonomic nervous system, offering clues for earlier diagnosis.

A national survey found that over half of Americans mistakenly believe women cannot safely give birth in their 40s.

A study highlights the need for culturally responsive, patient-centered care to address the experiences of Black women with endometriosis.

A study found that individuals’ ability to achieve their pregnancy preferences differs across sociodemographic factors.

Infants born to mothers in rural areas face greater odds of low Apgar scores and limited prenatal care access.

Ethan Lowder, BA, and Alexander Nagrebetsky, MD, MSc, reported that nearly 80% of children fast longer than recommended before surgery.

Women with prior cesarean delivery are more likely to experience severe pain, sleep disturbances, and daily activity disruption postpartum.